Author： Daniel D.G. Copeland L.F.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.4, 2000-04, pp. : 819-828
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Ziprasidone: a new atypical antipsychotic
By Arnold Lesley M McElroy Susan L Keck Paul E
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. :
Ziprasidone and the Corrected QT Interval: A Comprehensive Summary of Clinical Data
By Camm A. John
CNS Drugs, Vol. 26, Iss. 4, 2012-04 ,pp. :
Clinical overview of the novel inotropic agent toborinone
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. :